References
- Gulati, M., Grover, M., Singh, S., Singh, M., 1998. Lipophilic drug derivatives in liposomes. Int. J. Pharm. 165, 129-168. https://doi.org/10.1016/S0378-5173(98)00006-4
- Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., Nishida, M., Kihara, S., Sakai, N., Nakajima, T., Hasegawa, K., Muraguchi, M., Ohmoto, Y., Nakamura, T., Yamashita, S., Hanafusa, T., Matsuzawa, Y., 2000. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20, 1595-1599. https://doi.org/10.1161/01.ATV.20.6.1595
- Inoue, M., Maehata, E., Yano, M., Taniyama, M., Suzuki, S., 2005. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism 54, 281-286. https://doi.org/10.1016/j.metabol.2004.09.006
- Ishii, F., Nagasaka, Y., 2001. Simple and convenient method for estimation of marker entrapped in liposomes. J. Dispersion Sci. Technol. 22, 97-101. https://doi.org/10.1081/DIS-100102684
- Jeong, U.H., Jung, J.H., Davaa, E., Park, S.J., Myung, C.S., Park, J.S., 2009. Effect of drug loading on the physicochemical properties and stability of cationic lipid-based plasmid DNA complexes. J. Kor. Pharm. Sci. 39, 339-343. https://doi.org/10.4333/KPS.2009.39.5.339
- Kang, J.W., Davaa, E., Kim, Y.T., Park, J.S., 2010. A new vaginal delivery system of amphotericin B: a dispersion of cationic liposomes in a thermosensitive gel. J. Drug Target. 18, 637-644. https://doi.org/10.3109/10611861003649712
- Lebovitz, H.E., 2002. Differentiating members of the thiazolidinedione class: a focus on safety. Diabetes Metab. Res. Rev. 18, S23-29. https://doi.org/10.1002/dmrr.252
- Nan, M.H., Park, J.S., Myung, C.S., 2010. Construction of adiponectin-encoding plasmid DNA and gene therapy of non-obese type 2 diabetes mellitus. J. Drug Target. 18, 67-77. https://doi.org/10.3109/10611860903225719
- Qi, Y., Takahashi, N., Hileman, S.M., Patel, H.R., Berg, A.H., Pajvani, U.B., Scherer, P.E., Ahima, R.S., 2004. Adiponectin acts in the brain to decrease body weight. Nat. Med. 10, 524-529. https://doi.org/10.1038/nm1029
- Wiradharma, N., Tong, Y.W., Yang, Y.Y., 2009. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect. Biomaterials 30, 3100-3109. https://doi.org/10.1016/j.biomaterials.2009.03.006
- Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M.L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P., Kadowaki, T., 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941-946. https://doi.org/10.1038/90984